Literature DB >> 364232

Neurotensin, a biologically active peptide.

G Bissette, P Manberg, C B Nemeroff, A J Prange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 364232     DOI： 10.1016/0024-3205(78)90201-1

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  8 in total

1.  Mechanisms contributing to the regional haemodynamic effects of neurotensin in conscious, unrestrained Long Evans rats.

Authors:  H Bachelard; S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Responses of preoptic thermosensitive neurons to poikilothermia-inducing peptides--bombesin and neurotensin.

Authors:  T Hori; M Yamasaki; T Kiyohara; M Shibata
Journal:  Pflugers Arch       Date:  1986-11       Impact factor: 3.657

3.  Structure-antinociceptive activity studies with neurotensin.

Authors:  S Furuta; K Kisara; S Sakurada; T Sakurada; Y Sasaki; K Suzuki
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

4.  The effect of neurotensin on the concentration of cholesterol and bile acids in the guinea pig.

Authors:  L Peric-Golia; C F Gardner; D E Wilson; M Peric-Golia
Journal:  Lipids       Date:  1984-10       Impact factor: 1.880

5.  The stimulatory effects of neurotensin and related peptides in rat stomach strips and guinea-pig atria.

Authors:  R Quirion; D Regoli; F Rioux; S St-Pierre
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

6.  Structure-activity studies with neurotensin: analysis of positions 9, 10 and 11.

Authors:  R Quirion; D Regoli; F Rioux; S St-Pierre
Journal:  Br J Pharmacol       Date:  1980-08       Impact factor: 8.739

Review 7.  Neuropeptides in dopamine-containing regions of the brain.

Authors:  A Albanese; M C Altavista
Journal:  Ital J Neurol Sci       Date:  1984-12

8.  Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor.

Authors:  Corey A Carter; Aiste Degesys; Bryan Oronsky; Jan Scicinski; Scott Z Caroen; Arnold L Oronsky; Tony Reid; Pedro Cabrales; Joe Roswarski
Journal:  Case Rep Oncol       Date:  2015-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.